Mouscron Pharma SRL
2.8 FTEThe score of Mouscron Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -26 % Total assets +3 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mouscron Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Mouscron Pharma's financial analysis
- Solvency62.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mouscron Pharma
Mouscron Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0442.796.288
- VAT number
- BE0442796288
- Peppol
- Registered · 0208:0442796288 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 1990
- Registered office
- 7700 Mouscron
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mouscron Pharma (SRL) has been based in Mouscron since 1990, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 70,063 € and equity of €2.03m; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 62.6%, above the median of its sector (41.5%).
Companies similar to Mouscron Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- E.V.N. Pharma Retail sale of pharmaceutical products Grimbergen · balance sheet €3.28m
- GDK Farma Retail sale of pharmaceutical products Grimbergen · balance sheet €3.07m
- Xpharma Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet €3.07m
- Extra-Pharma Retail sale of pharmaceutical products Kapellen · balance sheet €3.06m
- Unifarma Retail sale of pharmaceutical products Kortrijk · balance sheet €3.56m
- VAN Nuffel - DE Vriendt Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet €2.84m
- Crossver Retail sale of pharmaceutical products Wielsbeke · balance sheet €3.78m
Frequently asked questions about Mouscron Pharma
What is the revenue of Mouscron Pharma?
Mouscron Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mouscron Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0442796288 for Mouscron Pharma, if the company is VAT-registered. Its company number (CBE) is 0442.796.288.
Where is the registered office of Mouscron Pharma?
According to the CBE register, the registered office of Mouscron Pharma is in 7700 Mouscron.
What is the equity of Mouscron Pharma?
At the close of the 2025 financial year, the equity of Mouscron Pharma amounts to 2,032,410 €, a solvency of 62.6% of total assets.
How many people work at Mouscron Pharma?
2.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Mouscron Pharma?
The register lists 5 active mandates at Mouscron Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mouscron Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →